In Hee Lee

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Topics

Breast Cancer Risk

Chemotherapy Induced

Top Venues

Cancer chemotherapy and pharmacology

Breast cancer research and treatment

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

In Hee Lee, Soo Jung Lee, Byeongju Kang, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Ji-Young Park, Nora Jee-Young Park, Eun Ae Kim, Jieun Kang, Yee Soo Chae
Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer. Breast cancer research and treatment (2024)
In Hee Lee, Soo Jung Lee, Juhyung Kim, Yoon Hee Lee, Gun Oh Chong, Jong Mi Kim, Juhun Lee, Nan Young Lee, Seo Young Park, Dea Gy Hong, Yee Soo Chae
Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer. Cancer chemotherapy and pharmacology 94 (1) (2024)
In Hee Lee, Soo Jung Lee, Juhyung Kim, Yoon Hee Lee, Gun Oh Chong, Jong Mi Kim, Juhun Lee, Nan Young Lee, Seo Young Park, Dea Gy Hong, Yee Soo Chae
Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer. Cancer chemotherapy and pharmacology (2024)
In Hee Lee, Soo Jung Lee, Byeongju Kang, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Ji-Young Park, Nora Jee-Young Park, Eun Ae Kim, Jieun Kang, Yee Soo Chae
Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer. Breast cancer research and treatment 205 (1) (2024)
In Hee Lee, Soo Jung Lee, Juhyung Kim, Yoon Hee Lee, Gun Oh Chong, Jong Mi Kim, Juhun Lee, Nan Young Lee, Seo Young Park, Dea Gy Hong, Yee Soo Chae
Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer. Cancer chemotherapy and pharmacology 94 (1) (2024)
In Hee Lee, Soo Jung Lee, Byeongju Kang, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Ji-Young Park, Nora Jee-Young Park, Eun Ae Kim, Jieun Kang, Yee Soo Chae
Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer. Breast cancer research and treatment 205 (1) (2024)
In Hee Lee, Soo Jung Lee, Byeongju Kang, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Ji-Young Park, Nora Jee-Young Park, Eun Ae Kim, Jieun Kang, Yee Soo Chae
Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer. Breast cancer research and treatment 205 (1) (2024)
Jeeyeon Lee, Ji Yeon Ham, Ho Yong Park, Jin Hyang Jung, Wan Wook Kim, Byeongju Kang, Yee Soo Chae, Soo Jung Lee, In Hee Lee, Nan Young Lee
Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers. Scientific reports 12 (1) (2022)
In Hee Lee, Soo Jung Lee, Byung Woog Kang, Yee Soo Chae, Dongwon Baek, Soyoon Hwang, Hye Jin Kim, Su Yeon Park, Jun Seok Park, Gyu Seog Choi, Jae Chul Kim, Jong Gwang Kim
Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer. Cancer chemotherapy and pharmacology 78 (6) (2016)